Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sanofi-Aventis S.A. ADR
(NQ:
SNY
)
49.28
+0.59 (+1.21%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Sanofi-Aventis S.A. ADR
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Vanda Pharmaceuticals Acquires Rights To Multiple Sclerosis Drug From Johnson & Johnson's Company
December 07, 2023
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) has acquired U.S.
Via
Benzinga
Sanofi Lays Out Ambitious Plans To Bolster Its Pipeline, Highlights 12 Blockbuster Opportunities
December 07, 2023
Sanofi SA (NASDAQ: SNY) says it has 12 drugs in development with a blockbus
Via
Benzinga
IGM Biosciences Increases Focus On Autoimmune Diseases, Stops All Blood Cancer-Related Studies
December 06, 2023
IGM Biosciences Inc (NASDAQ: IGMS) said it will focus on two strategic areas: treating colorectal cancer using IgM death receptor 5 (DR5) agonist antibodies and treating autoimmune diseases using IgM...
Via
Benzinga
Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
December 06, 2023
Merck KGaA (OTC: MKGAF) (OTC:
Via
Benzinga
Don't overlook NASDAQ:SNY—it's a hidden gem with strong fundamentals and an attractive price tag.
December 06, 2023
SANOFI-ADR (NASDAQ:SNY) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via
Chartmill
Investor Demand for Clarity Grows Amid Sanofi's Strategic R&D Shift
December 05, 2023
Sanofi SA's (NASDAQ: SNY) CEO, Paul Hudson, is confronting mounting investor pressure as shareholders seek concrete details about the company's expanded R&D budget.
Via
Benzinga
How Is The Market Feeling About Sanofi?
November 30, 2023
Via
Benzinga
Is NASDAQ:SNY a Good Fit for Dividend Investing?
November 21, 2023
Is SANOFI-ADR (NASDAQ:SNY) a Good Fit for Dividend Investing?
Via
Chartmill
Looking Into Sanofi's Recent Short Interest
November 13, 2023
Via
Benzinga
Weight Loss Drugs And Associated Suicidal Thoughts - European Drug Regulator Seeks Clarifications From Drug Makers
December 01, 2023
European Medicines Agency (EMA) will request further clarifications from drugmakers of GLP-1 receptor agonists for diabetes and weight loss, including Novo Nordisk A/S's (NYSE: NVO) popular therapies...
Via
Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
November 30, 2023
These stocks aren't popular on the market right now, but investors shouldn't let that scare them off.
Via
The Motley Fool
Regeneron, Sanofi Plot A Major Expansion That Could Add $4 Billion In Future Sales
November 27, 2023
Regeneron and Sanofi are partnered on Dupixent, a treatment for conditions tied to type 2 inflammation.
Via
Investor's Business Daily
Sanofi/Regeneron's Blockbuster Prescription Drug Dupixent Shows Additional Promise In Chronic Lung Disorder
November 27, 2023
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (NASDAQ: SNY) announced the second Dupixent (dupilumab) Phase 3 chronic obstructive pulmonary disease (COPD) trial (NOTUS) showed that...
Via
Benzinga
Antibody Player Dianthus Therapeutics Has Potential Amid Active M&A Landscape in Complement-Focused Firms: Analyst
November 22, 2023
Wedbush initiated coverage on Dianthus Therapeutics Inc (NASDAQ: DNTH), noting its lead program DNTH103 as a well-positioned monoclonal antibody directed against the active form of the
Via
Benzinga
This Stock Just Dropped By 15%: Is It a Buy?
November 03, 2023
Now could be a great opportunity to buy low.
Via
The Motley Fool
Is NASDAQ:SNY a Good Fit for Dividend Investing?
October 31, 2023
Is SANOFI-ADR (NASDAQ:SNY) a Good Fit for Dividend Investing?
Via
Chartmill
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
US CDC Rolls Out Additional Doses For Sanofi/AstraZeneca Recently Approved Respiratory Infection Drug As Demand Surges
November 17, 2023
The U.S.
Via
Benzinga
Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B
November 16, 2023
Sanofi SA (NYSE: SNY) has reportedly initiated talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at over...
Via
Benzinga
Don't overlook NASDAQ:SNY—it's a hidden gem with strong fundamentals and an attractive price tag.
November 15, 2023
SANOFI-ADR (NASDAQ:SNY) is an undervalued gem with solid fundamentals.
Via
Chartmill
Celldex Makes A Bullish Move As It Looks To Take On Regeneron, Sanofi
November 06, 2023
The company is looking to take on Regeneron and Sanofi's Dupixent in skin diseases.
Via
Investor's Business Daily
Why Is Gene Therapy Company MeiraGTx Stock Trading Higher Today?
October 30, 2023
MeiraGTx Holdings plc (NASDAQ: MGTX) shares are trading higher after French pharma giant Sanofi SA (NASDAQ: SNY) made a $30 million
Via
Benzinga
Sanofi (SNY) Q3 2023 Earnings Call Transcript
October 27, 2023
SNY earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Friday's Intraday Session
October 27, 2023
Via
Benzinga
Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday's Mid-Day Session
October 27, 2023
Gainers Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ-MET fusion.
Via
Benzinga
Stock Market Correction Intensifies; Google, Meta, Microsoft, Amazon Are Big Earnings Movers: Weekly Review
October 27, 2023
Microsoft, Google, Amazon and Meta led big earnings.
Via
Investor's Business Daily
Why Are Stocks Up Today?
October 27, 2023
Stocks are up on Friday as investors react to a positive earnings report from Amazon that has other tech stocks moving in sympathy with AMZN.
Via
InvestorPlace
Why Is Nikola (NKLA) Stock Up 4% Today?
October 27, 2023
Nikola stock is on the rise Friday as shares of NKLA continue a climb this week on positive news of $165 million award from a court case.
Via
InvestorPlace
SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff
October 27, 2023
The happy talk in Sanofi's press release didn't help with analysts, who have been disappointed in the company and SNY stock all year.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 27, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.